Centessa Pharmaceuticals PLC ADR

Yahoo Finance • 4 days ago

Looks Like M&A Week in 3 Different Sectors

In this episode of Motley Fool Money, Motley Fool contributors Tyler Crowe, Matt Frankel, and Lou Whiteman discuss: Sysco’s $26 billion deal for Restaurant Depot. McCormick’s $44 billion deal for Unilever’s food division. The track record... Full story

Yahoo Finance • 7 days ago

Eli Lilly Obesity Pill Approval And Sleep Deal Reshape Growth Story

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Eli Lilly (NYSE:LLY) has received U.S. FDA approval for Foundayo,... Full story

Yahoo Finance • 7 days ago

Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus

Wall Street’s major market averages ended mixed on Thursday as markets assessed President Donald Trump’s address to the nation and the latest developments in the Middle East conflict. The tech-focused Nasdaq Composite finished +0.1%. At t... Full story

Yahoo Finance • 8 days ago

Jim Cramer Believes Eli Lilly’s “Weight Loss Pill Will Be a Blockbuster”

Eli Lilly and Company (NYSE:LLY) is among the stocks in focus, as Jim Cramer analyzed the broader market impact of the recent AI data center rally. Cramer highlighted the FDA approval of the company’s new weight loss pill and its acquisiti... Full story

Yahoo Finance • 10 days ago

Eli Lilly (LLY) to Acquire Centessa Pharmaceuticals in $7.8B Deal

Eli Lilly and Company (NYSE:LLY) is one of the best US stocks to buy and hold for the next 3 years. On March 31, Eli Lilly announced an agreement to acquire Centessa Pharmaceuticals in a deal valued at $7.8 billion. The acquisition diversi... Full story

Yahoo Finance • 11 days ago

Eli Lilly (LLY) Stock Trades Up, Here Is Why

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 4.7% in the afternoon session after the FDA approved Foundayo (orforglipron), its highly anticipated once-daily oral weight loss pill. Foundayo offers a n... Full story

Yahoo Finance • 11 days ago

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Boeing, Datadog, Disney, Formula One Group, Nike, Rivian, Rocket Lab, ServiceNow, and More

Quick Read Stocks were higher across all major indices, as hopes for a speedy end to the Iran war remain in place. Short covering and end-of-quarter “window dressing” were cited as two reasons that aided the massive rally. With first-quar... Full story

Yahoo Finance • 12 days ago

Alkermes (ALKS) Nears 52-Week High on Increasing Orexin Receptor Market Interest

Alkermes PLC (NASDAQ:ALKS) is one of the 10 Stocks Dominating Today’s Market Surge. Alkermes extended gains for a second day on Tuesday to nearly hit its 52-week high, as investors digested the growing interest in the orexin receptor agon... Full story

Yahoo Finance • 12 days ago

Centessa (CNTA) Soars to All-Time High on 38% Upside from Eli Lilly Merger

Centessa Pharmaceuticals PLC (NASDAQ:CNTA) is one of the 10 Stocks Dominating Today’s Market Surge. Centessa soared to a new all-time high on Tuesday, as investors gobbled up shares following news that it is set to be acquired by giant we... Full story

Yahoo Finance • 12 days ago

The Year Is Off to the Strongest Start for Big Deals Ever

Companies are plowing ahead with corporate tie-ups and investments despite a war and slumping stocks. Continue Reading... Full story

Yahoo Finance • 12 days ago

Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly

Nxera Pharma Lilly to gain ownership of Centessa's OX2R agonist pipeline designed to improve outcomes across sleep-wake disorders Centessa’s OX2R agonist pipeline was jointly discovered by Nxera and Centessa, and Nxera retains a material... Full story

Yahoo Finance • 12 days ago

Eli Lilly Centessa Deal Expands Sleep Pipeline And Valuation Debate

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Eli Lilly (NYSE:LLY) has agreed to acquire Centessa Pharmaceuticals in a deal valued at up to US$7.8b. The transaction focuses on... Full story

Yahoo Finance • 12 days ago

Eli Lilly to Acquire Centessa in Up to $7.8 Billion Deal, 70% Premium

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) is moving to extend its growth runway beyond obesity, agreeing to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion. The structure includes an upfront pa... Full story

Yahoo Finance • 12 days ago

Stocks Climb on Hopes for an End to Iran War

The S&P 500 Index ($SPX) (SPY) today is up +1.02%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.67%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.10%.  June E-mini S&P futures (ESM26) are up +1.10%, and June E-mini Nasdaq fut... Full story

Yahoo Finance • 12 days ago

Sector Update: Health Care Stocks Higher Late Afternoon

Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 2% and the St PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 12 days ago

Sector Update: Health Care Stocks Higher Tuesday Afternoon

Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index adding 1.5% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 12 days ago

Correction: Sector Update: Health Care Stocks Advance Premarket Tuesday

(Corrects the upfront cash consideration in the second paragraph to $6.3 billion.) Health care st PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n... Full story

Yahoo Finance • 12 days ago

Update: Eli Lilly to Acquire Centessa Pharmaceuticals in Deal Valued at Up to $7.8 Billion; Shares Rise

(Updates with the latest share price movement in the headline and last paragraph.) Eli Lilly (LLY PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n... Full story

Yahoo Finance • 12 days ago

Nvidia invests $2B in Marvell, Eli Lilly to buy drugmaker Centessa

Yahoo Finance Senior Reporter Brooke DiPalma takes a closer look at some of Tuesday morning's trending tickers and stories, including some of the latest deals and investments. Nvidia (NVDA) is investing $2 billion in Marvell (MRVL). Biog... Full story

Yahoo Finance • 12 days ago

Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio

Eli Lilly to acquire Centessa in $6.3B deal to expand neuroscience portfolio Proactive uses images sourced from Shutterstock Eli Lilly and Co $LLY said on Tuesday it will acquire Centessa Pharmaceuticals $CNTA for $38 per share in cash, w... Full story